Alpha Teknova (TKNO) Other Non-Current Liabilities (2020 - 2024)
Alpha Teknova (TKNO) posted quarterly Other Non-Current Liabilities of $10000.0 for Q4 2024, down 90.2% year-over-year from $102000.0 in Q1 2024, and down 66.67% quarter-over-quarter from $30000.0 in Q3 2024.
Alpha Teknova (TKNO) Other Non-Current Liabilities (2020 - 2024) Analysis & Trends
Alpha Teknova (TKNO) has reported Other Non-Current Liabilities for 5 consecutive years, with $10000.0 the latest figure, recorded in Q4 2024.
- In Q4 2024, Other Non-Current Liabilities fell 90.2% year-over-year to $10000.0; the TTM figure through Dec 2024 stood at $10000.0 (down 90.2% YoY), while the FY2024 annual figure was $10000.0, down 90.2% from the prior year.
- Other Non-Current Liabilities fell to $10000.0 in Q4 2024 per TKNO's latest filing, from $30000.0 in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $350000.0 in Q4 2020 and bottomed at $10000.0 in Q4 2024.
- Historically, Other Non-Current Liabilities has averaged $177000.0 across 5 years, with a median of $180000.0 in 2022.
- Annual changes were most pronounced in 2021 — Other Non-Current Liabilities decreased 22.0% — and 2024, when it plunged 90.2%.
- Alpha Teknova's Other Non-Current Liabilities stood at $350000.0 in 2020, then fell by 22.0% to $273000.0 in 2021, then sank by 30.04% to $191000.0 in 2022, then tumbled by 46.6% to $102000.0 in 2023, then slumped by 90.2% to $10000.0 in 2024.
- Business Quant data shows TKNO's Other Non-Current Liabilities at $10000.0 in Q4 2024, $30000.0 in Q3 2024, and $54000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.43 Bn | 43.46 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.72 Bn | 40.07 Bn | 2.15 Bn |
| 3 | Zoetis | 32.38 Bn | 30.70 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.13 Bn | 19.46 Bn | 683.80 Mn |
| 6 | Viatris | 18.87 Bn | 17.99 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.99 Bn | 11.46 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Alpha Teknova | 396.36 Mn | 378.93 Mn | 4.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 10,000.00 |
| Sep 30, 2024 | 30,000.00 |
| Jun 30, 2024 | 54,000.00 |
| Mar 31, 2024 | 78,000.00 |
| Dec 31, 2023 | 102,000.00 |
| Sep 30, 2023 | 125,000.00 |
| Jun 30, 2023 | 147,000.00 |
| Mar 31, 2023 | 169,000.00 |
| Dec 31, 2022 | 191,000.00 |
| Sep 30, 2022 | 212,000.00 |
| Jun 30, 2022 | 233,000.00 |
| Mar 31, 2022 | 253,000.00 |
| Dec 31, 2021 | 273,000.00 |
| Sep 30, 2021 | 293,000.00 |
| Jun 30, 2021 | 312,000.00 |
| Dec 31, 2020 | 350,000.00 |